Literature DB >> 23175668

Gestational age-dependent changes in gene expression of metabolic enzymes and transporters in pregnant mice.

Diana L Shuster1, Theo K Bammler, Richard P Beyer, James W Macdonald, Jesse M Tsai, Frederico M Farin, Mary F Hebert, Kenneth E Thummel, Qingcheng Mao.   

Abstract

Pregnancy-induced changes in drug pharmacokinetics can be explained by changes in expression of drug-metabolizing enzymes and transporters and/or normal physiology. In this study, we determined gestational age-dependent expression profiles for all metabolic enzyme and transporter genes in the maternal liver, kidney, small intestine, and placenta of pregnant mice by microarray analysis. We specifically examined the expression of genes important for xenobiotic, bile acid, and steroid hormone metabolism and disposition, namely, cytochrome P450s (Cyp), UDP-glucuronosyltranserases (Ugt), sulfotransferases (Sult), and ATP-binding cassette (Abc), solute carrier (Slc), and solute carrier organic anion (Slco) transporters. Few Ugt and Sult genes were affected by pregnancy. Cyp17a1 expression in the maternal liver increased 3- to 10-fold during pregnancy, which was the largest observed change in the maternal tissues. Cyp1a2, most Cyp2 isoforms, Cyp3a11, and Cyp3a13 expression in the liver decreased on gestation days (gd) 15 and 19 compared with nonpregnant controls (gd 0). In contrast, Cyp2d40, Cyp3a16, Cyp3a41a, Cyp3a41b, and Cyp3a44 in the liver were induced throughout pregnancy. In the placenta, Cyp expression on gd 10 and 15 was upregulated compared with gd 19. Notable changes were also observed in Abc and Slc transporters. Abcc3 expression in the liver and Abcb1a, Abcc4, and Slco4c1 expression in the kidney were downregulated on gd 15 and 19. In the placenta, Slc22a3 (Oct3) expression on gd 10 was 90% lower than that on gd 15 and 19. This study demonstrates important gestational age-dependent expression of metabolic enzyme and transporter genes, which may have mechanistic relevance to drug disposition in human pregnancy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23175668      PMCID: PMC3558854          DOI: 10.1124/dmd.112.049718

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  45 in total

Review 1.  Evaluation of Affymetrix Gene Chip sensitivity in rat hippocampal tissue using SAGE analysis. Serial Analysis of Gene Expression.

Authors:  Simon J Evans; Nicole A Datson; Mohamed Kabbaj; Robert C Thompson; Erno Vreugdenhil; E Ronald De Kloet; Stanley J Watson; Huda Akil
Journal:  Eur J Neurosci       Date:  2002-08       Impact factor: 3.386

2.  Longitudinal study of progestins, mineralocorticoids, and glucocorticoids throughout human pregnancy.

Authors:  H G Dörr; A Heller; H T Versmold; W G Sippell; M Herrmann; F Bidlingmaier; D Knorr
Journal:  J Clin Endocrinol Metab       Date:  1989-05       Impact factor: 5.958

3.  Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women.

Authors:  Jashvant D Unadkat; Diane W Wara; Michael D Hughes; Anita A Mathias; Diane T Holland; Mary E Paul; James Connor; Sharon Huang; Bach-Yen Nguyen; D Heather Watts; Lynne M Mofenson; Elizabeth Smith; Paul Deutsch; Kathleen A Kaiser; Ruth E Tuomala
Journal:  Antimicrob Agents Chemother       Date:  2006-12-11       Impact factor: 5.191

Review 4.  Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction.

Authors:  Marcella Martignoni; Geny M M Groothuis; Ruben de Kanter
Journal:  Expert Opin Drug Metab Toxicol       Date:  2006-12       Impact factor: 4.481

5.  Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan.

Authors:  J W Jonker; J W Smit; R F Brinkhuis; M Maliepaard; J H Beijnen; J H Schellens; A H Schinkel
Journal:  J Natl Cancer Inst       Date:  2000-10-18       Impact factor: 13.506

6.  The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study.

Authors:  Lin Zhou; Suresh Babu Naraharisetti; Honggang Wang; Jashvant D Unadkat; Mary F Hebert; Qingcheng Mao
Journal:  Mol Pharmacol       Date:  2007-12-13       Impact factor: 4.436

Review 7.  Hypoglycemics: pharmacokinetic considerations during pregnancy.

Authors:  Chagit Klieger; Erika Pollex; Aleksey Kazmin; Gideon Koren
Journal:  Ther Drug Monit       Date:  2009-10       Impact factor: 3.681

8.  Differential expression of extracellular matrix-mediated pathways in single-suture craniosynostosis.

Authors:  Brendan D Stamper; Sarah S Park; Richard P Beyer; Theo K Bammler; Frederico M Farin; Brig Mecham; Michael L Cunningham
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

9.  A reanalysis of a published Affymetrix GeneChip control dataset.

Authors:  Alan R Dabney; John D Storey
Journal:  Genome Biol       Date:  2006-03-22       Impact factor: 13.583

10.  Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice.

Authors:  M F Hebert; X Ma; S B Naraharisetti; K M Krudys; J G Umans; G D V Hankins; S N Caritis; M Miodovnik; D R Mattison; J D Unadkat; E J Kelly; D Blough; C Cobelli; M S Ahmed; W R Snodgrass; D B Carr; T R Easterling; P Vicini
Journal:  Clin Pharmacol Ther       Date:  2009-03-18       Impact factor: 6.903

View more
  24 in total

1.  Effect of pregnancy on the disposition of 2,2',3,5',6-pentachlorobiphenyl (PCB 95) atropisomers and their hydroxylated metabolites in female mice.

Authors:  Izabela Kania-Korwel; Christopher D Barnhart; Pamela J Lein; Hans-Joachim Lehmler
Journal:  Chem Res Toxicol       Date:  2015-08-13       Impact factor: 3.739

Review 2.  The organic anion transporter (OAT) family: a systems biology perspective.

Authors:  Sanjay K Nigam; Kevin T Bush; Gleb Martovetsky; Sun-Young Ahn; Henry C Liu; Erin Richard; Vibha Bhatnagar; Wei Wu
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

3.  Sources of Interindividual Variability.

Authors:  Yvonne S Lin; Kenneth E Thummel; Brice D Thompson; Rheem A Totah; Christi W Cho
Journal:  Methods Mol Biol       Date:  2021

Review 4.  The Placental Barrier: the Gate and the Fate in Drug Distribution.

Authors:  Nino Tetro; Sonia Moushaev; Miriam Rubinchik-Stern; Sara Eyal
Journal:  Pharm Res       Date:  2018-02-23       Impact factor: 4.200

Review 5.  Placental ABC Transporters: Biological Impact and Pharmaceutical Significance.

Authors:  Anand A Joshi; Soniya S Vaidya; Marie V St-Pierre; Andrei M Mikheev; Kelly E Desino; Abner N Nyandege; Kenneth L Audus; Jashvant D Unadkat; Phillip M Gerk
Journal:  Pharm Res       Date:  2016-09-19       Impact factor: 4.200

6.  Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes?

Authors:  Nina Isoherranen; Kenneth E Thummel
Journal:  Drug Metab Dispos       Date:  2013-02       Impact factor: 3.922

7.  Effect of gestational age on mRNA and protein expression of polyspecific organic cation transporters during pregnancy.

Authors:  Nora Lee; Mary F Hebert; Bhagwat Prasad; Thomas R Easterling; Edward J Kelly; Jashvant D Unadkat; Joanne Wang
Journal:  Drug Metab Dispos       Date:  2013-10-07       Impact factor: 3.922

8.  Maternal-fetal disposition of glyburide in pregnant mice is dependent on gestational age.

Authors:  Diana L Shuster; Linda J Risler; Chao-Kang J Liang; Kenneth M Rice; Danny D Shen; Mary F Hebert; Kenneth E Thummel; Qingcheng Mao
Journal:  J Pharmacol Exp Ther       Date:  2014-06-04       Impact factor: 4.030

9.  UDP-glucuronosyltransferase 1a enzymes are present and active in the mouse blastocyst.

Authors:  Abby C Collier; Yasuhiro Yamauchi; Brittany L M Sato; Luc R A Rougée; Monika A Ward
Journal:  Drug Metab Dispos       Date:  2014-09-08       Impact factor: 3.922

10.  Validation of murine and human placental explant cultures for use in sex steroid and phase II conjugation toxicology studies.

Authors:  Brittany L Sato; Monika A Ward; Joshua M Astern; Claire E Kendal-Wright; Abby C Collier
Journal:  Toxicol In Vitro       Date:  2014-10-02       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.